Furthermore, NAMPT-specific inhibitors reduce NAD+ levels by inhibiting energy metabolism pathways such as glycolysis, citric acid cycle, and OXPHOS, contributing to the suppression of cancer cell proliferation. Here, NAMPT is linked to cancer.